Answers are grounded in this paper and cite their sources.
Cohort study reveals lower systemic immune inflammation index predicts longer survival in advanced lung cancer, highlighting its utility as a biomarker for immunotherapy.
The Role of Immune-Inflammation Biomarkers to Predict the Response of Nivolumab in Second Line Treatment of Advanced Stage Non-Small Cell Lung Cancer L ung cancer is the most prevalent form of malignancy worldwide and ranks first in cancer-related mortality. [1,2] Te GLOBOCAN cancer statistics show that lung cancer was diagnosed in 41,264 people in Turkey in 2020.A total of 37,070 people lost their lives due to this disease. [3]Nonsmall cell lung cancer (NSCLC) constitutes 90% of all lung Objectives: In this study, the relationship between response to second-line nivolumab treatment in advanced nonsmall cell lung cancer (NSCLC) and systemic immune inflammation index (SII) was investigated.Methods: One hundred and twenty-nine patients with advanced NSCLC who received nivolumab in second line between July 2018 and July 2023 were included.The optimum cutoff value for neutrophil/lymphocyte ratio (NLR), SII, platelet/lymphocyte ratio (PLR) and body mass index (BMI) was calculated.Progression free survival (PFS) and overall survival (OS) were evaluated.Univariate and multivariate analysis were performed for all parameters for prognostic evaluation.Results: In univariate analysis, patients with low SII found longer PFS and OS (HR = 1.762 for PFS, 95% CI 1.053-2.949,p=0.031, for OS HR=1.433, 95% CI 1.011-2.031,p=0.043).However, in multivariate analysis, no significance was found between low SII and OS (HR=1.614for OS, 95%CI 0.984-2.648,p=0.058).No statistically significant relationship was found between NLR, PLR, BMI and Glasgow prognostic score (GPS) with OS and PFS.OS was found to be longer in patients with programmed cell death ligand 1 (PD-L1) of 1% and above and without liver metastasis (p=0.031 and p=0.040, respectively).Conclusion: Low SII before nivolumab treatment was associated with long PFS.A significant correlation was found between PD-L1 of 1% and above and OS.
No takes yet. Share an insight, caveat, or question.
Özlem Özkul (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: